Hypogonadism Recruiting Phase 2 Trials for Gonadorelin (DB00644)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02956447Administration of Kisspeptin in Patients With HyperprolactinemiaTreatment